Butyrate (Short-chain FA)
DIGESTIVE · Evidence Monograph
Butyrate (Short-chain FA) is an evidence-graded digestive monograph evaluated across 22 peer-reviewed PubMed studies (1 meta-analyses, 0 systematic reviews, and 0 randomized controlled trials, encompassing n = 29 cumulative participants). Current clinical evidence is rated GRADE Moderate (3.0 / 4.0) for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.
Evidence Supports Supplementation When:
- 01 Individuals seeking evidence-backed support for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support (supported by 22 indexed PubMed studies, GRADE Moderate).
- 02 Adults matching clinical trial dosing protocols (40.00 g · 100 g · 23.6 g) over a structured 21 days evaluation window.
- 03 Users who have verified compatibility with their gastrointestinal tolerance and current prescription regimen.
Avoid or Consult Physician When:
- 01 Patients on narrow-therapeutic-index prescription medications (anticoagulants, immunosuppressants, thyroid hormones) without medical supervision.
- 02 Pregnant or lactating women, pediatric individuals, or patients with severe hepatic or renal impairment unless explicitly prescribed by a physician.
- 03 Anyone already taking overlapping multivitamin or multi-ingredient complexes that would push daily intake above upper tolerability limits.